ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 66 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $54,000 | – | 12,581 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 751,012 | $3,841,000 | 3.73% |
| Healthcare Value Capital, LLC | 200,000 | $1,023,000 | 1.85% |
| DELTEC ASSET MANAGEMENT LLC | 574,886 | $2,941,000 | 0.74% |
| Kerrisdale Advisers, LLC | 229,347 | $1,173,000 | 0.74% |
| Mosaic Family Wealth, LLC | 91,314 | $609,000 | 0.25% |
| Worth Venture Partners, LLC | 77,384 | $396,000 | 0.23% |
| ARMISTICE CAPITAL, LLC | 536,000 | $2,742,000 | 0.18% |
| EMERALD ADVISERS, LLC | 639,094 | $3,269,000 | 0.15% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 609,019 | $3,115,000 | 0.14% |
| DUDLEY & SHANLEY, INC. | 67,400 | $345,000 | 0.08% |